Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
267-279
Author(s):
Nial J. Wheate and J. Grant Collins
What they are, How they Work and Why they do What they do? The Story of SV40-derived Gene Therapy Vectors and What They Have to Offer
Journal:
Current Gene Therapy
Volume:
5
Page:
151-165
Author(s):
David S. Strayer, Pierre Cordelier, Rumi Kondo, Bianling Liu, Alexey A. Matskevich, Hayley J. McKee, Carmen N. Nichols, Christine B. Mitchell, Dawn A. Geverd and Martyn K. White
Is the Vascular System a Main Target for Thyroid Hormones? From Molecular and Biochemical Findings to Clinical Perspectives
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
133-145
Author(s):
Laura Sabatino, Antonio Colantuoni and Giorgio Iervasi
TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
933-944
Author(s):
G. Fiorucci, S. Vannucchi, Maria V. Chiantore, Zulema A. Percario, E. Affabris and G. Romeo
Immunohistochemical and Serological 90K / Mac-2BP Detection in Hepatocellular Carcinoma Patients: Different Behaviour of Two Monoclonal Antibodies
Journal:
Medicinal Chemistry
Volume:
1
Page:
185-189
Author(s):
A. M. Valentini, P. A. Iacovazzi, M. Correale, M. Pirrelli, R. Armentano, S. Iacobelli, N. Tinari, I. Iurisci and M. L. Caruso
Clinical Applications of Cardiovascular Magnetic Resonance
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
457-475
Author(s):
Norbert Watzinger, Robert Maier, Ursula Reiter, Gert Reiter, Georg Fuernau, Manfred Wonisch, Friedrich M Fruhwald, Martin Schumacher, Robert Zweiker, Rainer Rienmueller and Werner Klein1
Hyaluronan and Hyaluronan Synthases: Potential Therapeutic Targets in Cancer
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
3-14
Author(s):
Sophia Adamia, Christopher A. Maxwell and Linda M. Pilarski
Development of Vasculature Targeting Strategies for the Treatment of Chronic Inflammatory Diseases
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
4
Page:
13-22
Author(s):
Girolamo Ranieri, Roberto Ria, Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti
Hypericin - The Facts About a Controversial Agent
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
233-253
Author(s):
A. Kubin, F. Wierrani, U. Burner, G. Alth and W. Grunberger
Subject Index to Volume 4
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
91-98
Author(s):
Bentham Science Publishers